Literature DB >> 11090871

Development of a patient-specific dyspnoea questionnaire in motor neurone disease (MND): the MND dyspnoea rating scale (MDRS).

C F Dougan1, C O Connell, E Thornton, C A Young.   

Abstract

Motor neurone disease (MND) is a progressive, unremitting and fatal disease. Respiratory dysfunction is common and a significant cause of morbidity. The relationship between subjective dyspnoea and objective measures of lung function have been unexplored in MND. Increasing interest in the specific treatment of respiratory symptoms in MND has highlighted the need for simple, reliable and valid measures to quantify the degree of dyspnoea in this condition. Several generic questionnaires have been developed to rate subjective breathlessness but are inappropriate for use in MND patients as they often assess dyspnoea by exercise-limitation. As yet, there are no published disease-specific measures to assess dyspnoea in MND. In order to accurately and reproducibly measure the subjective experience of dyspnoea in this patient group, we have developed and validated a novel patient-specific dyspnoea questionnaire, the MND dyspnoea rating scale (MDRS). It comprises three domains covering dyspnoea, emotion and mastery and is valid for use in MND patients at all stages of disease progression. In our cohort of 40 unselected patients with MND we have shown that the patients subjective experience of dyspnoea is closely related to emotion and psychological control over the disease. Dyspnoea is not related to objective measures of lung function such as vital capacity, irrespective of limb or bulbar presentation. In conclusion, vital capacity, although useful prognostically, is only one aspect of respiratory function in MND. The MDRS is a reliable and valid tool to rate subjective dyspnoea in MND.

Entities:  

Mesh:

Year:  2000        PMID: 11090871     DOI: 10.1016/s0022-510x(00)00415-9

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  3 in total

1.  Adaptation to Turkish and Reliability Study of the Revised Amyotrophic Lateral Sclerosis Functional Rating Scale (ALSFRS-R).

Authors:  Filiz Koç; Mehmet Balal; Turgay Demir; Z Nazan Alparslan; Yakup Sarica
Journal:  Noro Psikiyatr Ars       Date:  2016-09-01       Impact factor: 1.339

2.  Determinants of accepting non-invasive ventilation treatment in motor neurone disease: a quantitative analysis at point of need.

Authors:  Rosanna Cousins; Hikari Ando; Everard Thornton; Biswajit Chakrabarti; Robert Angus; Carolyn Young
Journal:  Health Psychol Behav Med       Date:  2013-11-01

3.  Thick Mucus in ALS: A Mixed-Method Study on Associated Factors and Its Impact on Quality of Life of Patients and Caregivers.

Authors:  Sarah K Bublitz; Eva Mie; Maria Wasner; Alexander Hapfelmeier; Jens Geiseler; Stefan Lorenzl; Andrea Sylvia Winkler
Journal:  Brain Sci       Date:  2022-02-11
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.